WO2024218571 - METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING EOSINOPHILIC ESOPHAGITIS
National phase entry:
Publication Number
WO/2024/218571
Publication Date
24.10.2024
International Application No.
PCT/IB2024/000197
International Filing Date
18.04.2024
Title **
[English]
METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING EOSINOPHILIC ESOPHAGITIS
[French]
MÉTHODES ET COMPOSITIONS POUR PRÉVENIR OU TRAITER L'OESOPHAGITE À ÉOSINOPHILES
Applicants **
REVOLO BIOTHERAPEUTICS LIMITED
Inventors
FOULKES, Roly
DE ALBA, Jorge
Priority Data
63/496,921
18.04.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2427 | |
| EPO | Filing, Examination, Granting | 12453 | |
| Japan | Filing, Examination, Granting | 2370 | |
| South Korea | Filing, Examination, Granting | 2506 | |
| USA | Filing, Examination, Granting | 5140 |
Total:
24,896
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Described herein are methods for preventing or treating eosinophilic esophagitis (EoE) by administrating peptides related to Chaperonin 60.1 to subjects afflicted with EoE.[French]
L'invention concerne des méthodes de prévention ou de traitement de l'oesophagite à éosinophiles (EoE) par administration de peptides associés à la chaperonine 60.1 à des sujets atteints d'EoE.